Spinal Fusion Devices Market - Insights
Spinal fusion devices are used to provide stability to spinal structure, which has lost stability due to a fracture, degenerative disorders of the spine, trauma, tumors, and deformity. Spinal cord injuries majorly happen due to various reasons such as a blocked blood supply, infections, injuries, and compression by a fractured bone or a tumor. Spinal fusion devices technology and mechanism of functioning has evolved over the years. Advanced plating systems offer improved stability and structural integrity. Spinal fusion devices have innovative locking mechanisms and screw systems, which can have self-drilling and self-tapping functions, made from modern manufacturing material such as titanium alloy, and single as well as double holes per vertebrae through which the screw fixation is done.
Rapid product launch and frequent approval of novel spinal fusion devices are expected to drive growth of the global spinal fusion market
In 2015, Aesculap Implant Systems, a division of B. BRAUN MELSUNGEN AG, launched Modulift Vertebral Body Replacement System (VBR). It is the latest generation of expandable cage technology. In 2017, Stryker’s Spine division launched Serrato pedicle screw, a unique dual-lead screw intended for use in the non-cervical spine. In 2016, Stryker launched Aero-C Cervical Stability System at the meeting of the American Academy of Orthopedic Surgeons in Orlando. Entry of these novel products in market is expected to support the growth of global spinal fusion devices market in near future. Furthermore, frequent approvals of innovative products is also expected to drive market growth. For instance in 2018, Orthofix International N.V., received U S Food and Drug Administration 510(k) clearance of FORZA XP Expandable Spacer System. FORZA XP is designed to restore normal disc height in patients suffering from degenerative disc disease. In 2016, Orthofix International N.V. received US Food and Drug Administration 510(k) clearance for FORZA PTC (Peek Titanium Composite) Spacer System, and Wenzel Spine, Inc., received clearance from the U.S. Food and Drug Administration (FDA) to market VariLift-LX, an interbody fusion device for stand-alone use in the lumbar spine.
The global spinal fusion devices market was valued at US$ 7,462.4 million in 2016 and is expected to witness a CAGR of 4.6% over the forecast period (2017 – 2025).
Figure 1. Global Spinal Fusion Devices Market Share (%), By Region, 2017 – 2025
Increasing prevalence of spinal deformities is expected to drive growth of the global spinal fusion device market
Factors responsible for spinal deformities include weight, diet, smoking, and other lifestyle factors. Early onset of degenerative spinal changes is attributed to the toxins in cigarette smoke damaging the cartilage of spine. According to World Health Organization (WHO), more than 1.1 billion people smoked tobacco in 2015 worldwide. According to a study published in SpineUniverse in 2017, disc herniation is the most common indication for spinal surgery, and around 75% of all spinal surgeries were performed for herniated disc. Increasing prevalence of spinal deformities due to unhealthy lifestyle and high chances of disc herniation are expected to drive growth of the spinal fusion devices market in near future.
Furthermore, key players in the spinal fusion devices market are focusing of strategic mergers and acquisitions to expand their product portfolio and to strengthen their position in new geographies. For instance in 2016, Zimmer acquired LDR Holding Corporation to enhance innovation and growth of their spine segment. In 2016, Globus Medical, Inc. acquired the international operations and distribution channels of Alphatec Holdings, Inc. This acquisition has expanded company's product portfolio and provided an immediate access to Japan and increased presence and penetration in other geographical areas, though the Alphatec's extensive international distributer to increase its international sales.
Key players operating in global spinal fusion devices market include Zimmer Biomet Holdings, Inc., Inc., Stryker Corporation, Inc., Exactech, Inc., Orthofix International N.V., Globus Medical, Inc., NuVasive, Inc., Medtronic Plc., Depuy Synthes, B. Braun Melsungen AG, Wenzel Spine, Inc., K2M Group Holdings, Inc., Centinel Spine, Inc., and Spineart Geneva SA.
Spinal fusion devices are used in spinal surgeries for patients suffering from various spinal diseases such as degenerative disc disease (DDD) and herniated disc. Spinal fusion devices are implanted into the spinal cord of the patient. The U.S. Food & Drug Administration (FDA) has placed spinal fusion devices under Class II of medical devices category. Moderate to severe spine problems need to be treated with surgical approach such as spinal fusion wherein the spinal vertebrae are either removed and fixated with implants or fused with the help of various fusion methods. Quality of life can be improved by spinal fusion surgeries. Rising prevalence of spinal cord diseases is expected to increase adoption of these surgeries.
Frequent approval from regulatory bodies to latest spinal fusion devices is expected to be the major driver for growth of global spinal fusion devices market over the forecast period. In 2016, Spineart Geneva SA received US Food and Drug Administration (FDA) clearance for its first range of titanium interbody, named - JULIET Ti PO, OL and TL interbody systems. The JULIETTi PO, OL and TL interbody systems are the range of titanium interbody implants. It include a full range of sizes to for diverse anatomies. The smooth bullet-shaped nose, lateral sides and chamfers of the implant are polished to preserve endplates, nerve roots, and soft tissues during insertion. The Ti-LIFE Technology micro-porous scaffold mimics the bone trabecular structure, which enables cell colonization and promotes bone ingrowth. In 2016, Centinel Spine, Inc. received U.S. FDA approval for STALIF L Minimally-Invasive Lateral Integrated Interbody System. It has advantages in minimally-invasive spinal fusion surgery. Furthermore, increasing prevalence of spinal disorder is also expected to increase demand for spinal fusions devices and hence is expected to drive spinal fusion devices market growth in near future. For instance, according to a study published by World Health Organization (WHO) in 2013, globally around 250,000 and 500,000 people suffer from a spinal cord injury (SCI). According to research published by the American Academy of Pain Medicine (AAPM) in 2016, women are 1.38 times more likely to suffer cervical degenerative disc disease (DDD) than men.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 46 market data tables and 40 figures on “Spinal Fusion Devices Market - Global forecast to 2025”
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.